Symptomatic benign breast disease and hormone replacement therapy

Area of Science:

• Oncology
• Endocrinology
• Women's Health

Background:

• Hormone replacement therapy (HRT) is commonly used by post-menopausal women.
• Concerns exist regarding HRT's potential influence on breast health and disease presentation.
• Understanding HRT's impact is crucial for accurate diagnosis and patient management.

Purpose of the Study:

• To investigate the effect of HRT on the presentation and diagnoses of breast conditions in post-menopausal women.
• To compare breast clinic presentation patterns between HRT users and non-users.
• To determine if HRT influences the likelihood of benign breast disease.

Main Methods:

• Retrospective review of patients presenting to a symptomatic Breast Clinic over a 5-year period.
• Comparison of 67 post-menopausal women (age <65) on HRT for >6 months with 144 post-menopausal women (age <65) not on HRT.
• Analysis of presentation patterns, intervention rates, and final diagnoses.

Main Results:

• No significant difference was observed in the pattern of breast symptom presentation between the HRT and non-HRT groups.
• The rate of clinical intervention (e.g., biopsy) did not differ between the two groups.
• Final diagnoses, including benign breast disease, showed no statistically significant variation between HRT users and non-users.

Conclusions:

• Hormone replacement therapy (HRT) does not appear to affect the presentation patterns of symptomatic breast conditions in post-menopausal women.
• HRT use is not associated with altered rates of intervention or specific diagnoses in this patient cohort.
• Further research may explore long-term effects, but current findings suggest HRT does not mask or alter typical benign breast disease presentations.